DRUG-INDUCED NARROWING OF THE WIDTH OF THE ZONE OF ENTRAINMENT AS A PREDICTOR OF THE SUBSEQUENT NON-INDUCIBILITY OF REENTRANT VENTRICULAR-TACHYCARDIA AFTER AN ADDITIONAL DOSE OF AN ANTIARRHYTHMIC DRUG
Y. Aizawa et al., DRUG-INDUCED NARROWING OF THE WIDTH OF THE ZONE OF ENTRAINMENT AS A PREDICTOR OF THE SUBSEQUENT NON-INDUCIBILITY OF REENTRANT VENTRICULAR-TACHYCARDIA AFTER AN ADDITIONAL DOSE OF AN ANTIARRHYTHMIC DRUG, HEART, 75(2), 1996, pp. 165-170
Background-The efficacy of drugs used to treat inducible monomorphic s
ustained ventricular tachycardia (VT) has been assessed by investigati
ng their ability to suppress inducibility, but the mechanism of the dr
ug action remains to be determined. Objectives-To determine electrophy
siological variables that predict inducibility, divided doses of class
I antiarrhythmic drugs were given and their effects were analysed, pa
rticularly the ability of the final dose to suppress inducibility. Met
hods-The excitable gap was estimated by the zone of entrainment, which
was defined as the difference between the cycle length of VT and the
longest paced cycle length that interrupted VT during entrainment of V
T with rapid pacing at paced cycle lengths in decrements of 10 ms. The
cycle length of VT, the block cycle length, and the zone of entrainme
nt were measured in the drug free state and after intermediate and fin
al doses of procainamide, disopyramide, cibenzoline, and mexiletine. R
esults-Sustained monomorphic VT with a mean (SD) cycle length of 285 (
43) ms was induced in 8 patients. It was entrained and interrupted at
the block cycle length of 231 (31) ms. The width of the zone of entrai
nment was 54 (23) ms. In 8 studies VT was not inducible at final doses
of procainamide in 4, cibenzoline in 1, and mexiletine in 3. In anoth
er 10 studies (procainamide in 4, disopyramide in 1, cibenzoline in 2,
and mexiletine in 3), VT remained inducible at the intermediate dose
and at the final dose. The cycle length of VT was prolonged to a simil
ar degree in studies of effective and ineffective drugs, but the cycle
length that blocked VT was longer at the intermediate dose of the eff
ective drugs. Consequently, the width of the zone of entrainment was s
ignificantly narrowed at the intermediate dose of effective drugs and
the width of the zone of entrainment was narrower than when ineffectiv
e drugs were given (22 (13) ms upsilon 76 (18) or 75 (37) ms at the in
termediate and final doses respectively (P < 0.02). Conclusion-Drugs t
hat narrowed the zone of entrainment were associated with non-inducibi
lity of VT after the final dose of the drug was given. The baseline va
riables did not predict the responses to class I antiarrhythmic drugs.